Name | N-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyl}-1-benzothiophene-2-carboxamide |
---|---|
Synonyms |
N-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl}-1-benzothiophene-2-carboxamide
N-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyl}-1-benzothiophene-2-carboxamide Benzo[b]thiophene-2-carboxamide, N-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyl]- |
Description | FAUC 365 is a highly dopamine D3 receptor-selective antagonist with Ki values of 0.5 nM, 340, 2600, and 3600 nM at D3, D4.4, D2short, and D2Long receptors, respectively. FAUC 365 can be used for the research of schizophrenia, and Parkinson's disease[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 680.3±55.0 °C at 760 mmHg |
Molecular Formula | C23H25Cl2N3OS |
Molecular Weight | 462.435 |
Flash Point | 365.2±31.5 °C |
Exact Mass | 461.109528 |
LogP | 7.14 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.638 |